已收盤 01-30 16:00:00 美东时间
+0.050
+0.19%
今日重点评级关注:瑞穗:维持Syndax制药"跑赢大市"评级,目标价从410美元升至600美元;HC Wainwright & Co.:维持60 Degrees Pharmaceuticals, Inc."买入"评级,目标价从6美元升至24美元
01-28 10:59
B. Riley Securities analyst Raj Sharma maintains Lincoln Educational Servs (NASDAQ:LINC) with a Buy and raises the price target from $27 to $33.
01-27 22:25
Lincoln Edu ( ($LINC) ) has provided an update. On December 19, 2025, Lincoln E...
2025-12-24 06:19
今日重点评级关注:RBC Capital:上调Neumora Therapeutics评级至"跑赢大市",目标价从4美元升至7美元;HC Wainwright & Co.:维持ProMIS Neurosciences"买入"评级,目标价从4美元升至18美元
2025-12-02 09:50
Barrington Research analyst Alexander Paris maintains Lincoln Educational Servs (NASDAQ:LINC) with a Outperform and maintains $27 price target.
2025-12-01 20:45
今日重点评级关注:Piper Sandler:维持MeiraGTx Hldgs"超配"评级,目标价从28美元升至30美元;RBC Capital:维持4D Molecular Therapeutics"跑赢大市"评级,目标价从26美元升至32美元
2025-11-12 11:43
Barrington Research analyst Alexander Paris maintains Lincoln Educational Servs (NASDAQ:LINC) with a Outperform and maintains $25 price target.
2025-11-11 21:02
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Lincoln Educational Services业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩:- **学生入学增长**:第三季度核心医疗保健项目(LPN和医疗助理)实现2%增长 - **平均学费收入**:每名学生平均收入增长约4%,其中2%-3%来自学费上涨 - **收入构成**:医疗保健及其他专业项目占总学生人数的20%,其中LPN和医疗助理项目占该细分市场的80%以上 - **学费调整**:根据不同项目,学费上涨3%或更少 ## 2. 财务指标变化:- **每学生平均收入增长4%**:主要由学费上涨(2%-3%)、项目组
2025-11-11 12:13
Lincoln Educational Servs (NASDAQ:LINC) raises FY2025 sales outlook from $490.000 million-$500.000 million to $505.000 million-$510.000 million vs $494.052 million estimate.
2025-11-10 21:03
Companies Reporting Before The Bell • CBAK Energy Tech (NASDAQ:CBAT) is likely ...
2025-11-10 19:12